IL7 and cancer: Given that tight control of signaling mediated by IL-7 is essential to support and maintain immune homeostasis, it is not surprising that dysregulation of its stimulation leads to a disrupted lymphoid development and pathophysiology in different types of conditions including autoimmune diseases and cancer.